- CA$1.21bn
- CA$1.48bn
- CA$4.64bn
- 68
- 87
- 76
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,460 | 3,644 | 3,977 | 4,696 | 4,644 |
Cost of Revenue | |||||
Gross Profit | 368 | 401 | 367 | 356 | 256 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,353 | 3,494 | 3,859 | 4,599 | 4,406 |
Operating Profit | 107 | 150 | 119 | 97.2 | 237 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 86.8 | 124 | 73.8 | 43 | 178 |
Provision for Income Taxes | |||||
Net Income After Taxes | 72.9 | 88 | 49.7 | 30.4 | 162 |
Net Income Before Extraordinary Items | |||||
Net Income | 72.9 | 88 | 49.7 | 30.4 | 162 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 83 | 98.3 | 60 | 40.8 | 172 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.16 | 0.256 | 0.761 | 0.442 | 0.34 |
Dividends per Share |